Lesion Quantification
Accurate segmentation and longitudinal tracking of FLAIR, T2* GRE, and SWI lesions.
AI Neurology & Neuro-Oncology
NeuroQuant® Lesion Monitoring
Automated Brain Lesion Tracking
NeuroQuant® Lesion Surveillance
Automated brain lesion quantification, visualization, and tracking over time to support clinical assessment, including monitoring patients receiving anti-amyloid therapy.
NeuroQuant® Lesion Surveillance quantifies brain lesions and tracks changes over time, supporting radiologists and neurologists in assessing and monitoring brain changes, including those that may occur in patients with Alzheimer’s disease receiving anti-amyloid therapy. Consistent, structured measurements across baseline and follow-up MRI scans help clinicians assess treatment eligibility and monitor therapy-associated imaging findings.
Comprehensive Brain Lesion Tracking
AI-Assisted Anti-Amyloid Therapy Monitoring
Support clinical assessment with objective volumetric data and color-coded brain structure images to inform diagnosis, treatment, and lifestyle planning. Assess lesion dissemination and distribution patterns, identify areas with the greatest lesion burden, and track lesions across orthogonal views.
NeuroQuant®
Lesion Surveillance Benefits
Eligibility Screening
Objective lesion quantification at baseline, helping clinicians document and contextualize findings.
OEM Protocol Standardization
To ensure reproducible outcomes and accuracy over time.
Longitudinal Disease Tracking
Monitor lesion counts and maximum diameters over time, with comparisons to baseline and prior timepoints.
Reports
NeuroQuant® Lesion Surveillance
Quantitative reports that support physicians in monitoring FLAIR and T2* GRE/SWI lesions over time through comparison with baseline imaging.
GRE Surveillance
The NeuroQuant® Lesion Surveillance GRE Report analyzes and tracks T2* GRE/SWI lesions, providing counts and locations of microhemorrhages and superficial siderosis.
FLAIR Surveillance Report
The NeuroQuant® Brain Tumor Metastasis Report detects, measures, and tracks lesions over time, highlighting new, resolved, shrinking, and enlarging tumors to simplify interpretation and support clinical decision-making.
Take the next step
NeuroQuant® Brain Tumor
FDA-cleared software for advanced brain tumor analyses
Powered by AI, NeuroQuant® Brain Tumor assists radiologists, oncologists, neurosurgeons, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.
Request a demoLet’s discuss your brain tumor imaging workflow.
